Leqembi Receives Positive Public Reimbursement Recommendation in Canada BioArctic announced that CDA-AMC has issued a final recommendation supporting public reimbursement of Leqembi (lecanemab) for el...
Takeaways: Silo Pharma’s CIPO Notice of Allowance for SPC‑15 strengthens its IP moat around a prophylactic, intranasal 5‑HT4 agonist approach for PTSD and stress‑induced disorders, complementing a rec...
Jamieson Wellness to be acquired by Kirin in C$2.5 billion transaction Jamieson Wellness announced that it has entered into a definitive agreement to be acquired by Kirin Holdings Company for C$45.75 ...
Health Canada authorizes P-I clinical trial of Moderna’s mRNA vaccine for Bundibugyo Ebola Health Canada has authorized Moderna to initiate a P-I clinical trial of its candidate mRNA vaccine for Ebola...
GSK’s Shingrix prefilled syringe presentation approved in Canada GSK Canada announced that Health Canada has approved a prefilled syringe presentation of Shingrix (Recombinant Zoster Vaccine) fo...
CDA-AMC recommends public reimbursement of LEQEMBI (lecanemab) for early Alzheimer’s disease Eisai Canada announced that Canada’s Drug Agency (CDA-AMC) has issued a positive recommendation...
Clinuvel’s Scenesse (afamelanotide) approved in Canada for erythropoietic protoporphyria Health Canada has approved Clinuvel’s Scenesse (afamelanotide) for the prevention of phototoxicity ...
